BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 19393652)

  • 21. Molecular chaperones in cellular protein folding.
    Hartl FU; Martin J
    Curr Opin Struct Biol; 1995 Feb; 5(1):92-102. PubMed ID: 7773752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular chaperones and protein quality control.
    Bukau B; Weissman J; Horwich A
    Cell; 2006 May; 125(3):443-51. PubMed ID: 16678092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytosolic chaperonins: a question of promiscuity.
    Clarke AR
    Mol Cell; 2006 Oct; 24(2):165-7. PubMed ID: 17052449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to the isolation and characterization of molecular chaperones.
    Nicoll WS; Boshoff A; Ludewig MH; Hennessy F; Jung M; Blatch GL
    Protein Expr Purif; 2006 Mar; 46(1):1-15. PubMed ID: 16199180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Principles of chaperone-mediated protein folding.
    Hartl FU
    Philos Trans R Soc Lond B Biol Sci; 1995 Apr; 348(1323):107-12. PubMed ID: 7770479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators.
    Henderson B
    Cell Biochem Funct; 2010 Jan; 28(1):1-14. PubMed ID: 19830685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirt1’s beneficial roles in neurodegenerative diseases - a chaperonin containing TCP-1 (CCT) connection?
    Gan BQ; Tang BL
    Aging Cell; 2010 Oct; 9(5):924-9. PubMed ID: 20569238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flexible nets of malleable guardians: intrinsically disordered chaperones in neurodegenerative diseases.
    Uversky VN
    Chem Rev; 2011 Feb; 111(2):1134-66. PubMed ID: 21086986
    [No Abstract]   [Full Text] [Related]  

  • 29. HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease.
    Prodromou C; Aran-Guiu X; Oberoi J; Perna L; Chapple JP; van der Spuy J
    Subcell Biochem; 2023; 101():389-425. PubMed ID: 36520314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular chaperones in cellular protein folding.
    Hartl FU
    Nature; 1996 Jun; 381(6583):571-9. PubMed ID: 8637592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Principles of chaperone-assisted protein folding: differences between in vitro and in vivo mechanisms.
    Frydman J; Hartl FU
    Science; 1996 Jun; 272(5267):1497-502. PubMed ID: 8633246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis.
    Roh SH; Kasembeli M; Bakthavatsalam D; Chiu W; Tweardy DJ
    Int J Mol Sci; 2015 Nov; 16(11):26706-20. PubMed ID: 26561808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
    Nakamura T; Lipton SA
    Cell Death Differ; 2007 Jul; 14(7):1305-14. PubMed ID: 17431424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging roles of J proteins in neurodegenerative disorders.
    Gibbs SJ; Braun JE
    Neurobiol Dis; 2008 Nov; 32(2):196-9. PubMed ID: 18760363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation.
    Vang S; Corydon TJ; Børglum AD; Scott MD; Frydman J; Mogensen J; Gregersen N; Bross P
    FEBS J; 2005 Apr; 272(8):2037-49. PubMed ID: 15819894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling of possible subunit arrangements in the eukaryotic chaperonin TRiC.
    Miller EJ; Meyer AS; Frydman J
    Protein Sci; 2006 Jun; 15(6):1522-6. PubMed ID: 16672233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytosolic protein quality control system--the role of molecular chaperones in the biology of neurodegenerative diseases].
    Guenther I; Kedzierska-Mieszkowska S
    Postepy Biochem; 2011; 57(3):274-82. PubMed ID: 22235653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential ATP-induced allosteric transitions of the cytoplasmic chaperonin containing TCP-1 revealed by EM analysis.
    Rivenzon-Segal D; Wolf SG; Shimon L; Willison KR; Horovitz A
    Nat Struct Mol Biol; 2005 Mar; 12(3):233-7. PubMed ID: 15696173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dual role of chaperones in the response of a cell and of a whole organism to stress].
    Margulis BA; Guzhova IV
    Tsitologiia; 2009; 51(3):219-28. PubMed ID: 19435276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.